Vident Investment Advisory, LLC Dr Reddys Laboratories LTD Transaction History

Vident Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$53.34 - $63.11 $103,426 - $122,370	1,939 Added 12.49%	17,463 $1.1 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $148,436 - $163,673	2,875 Added 22.73%	15,524 $883,000
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $646,996 - $726,685	12,649 New	12,649 $654,000
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $186,223 - $218,161	3,753 New	3,753 $207,000

256

37.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.